GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (STU:1OA) » Definitions » YoY EBITDA Growth

Blueberries Medical (STU:1OA) YoY EBITDA Growth : 0.00% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Blueberries Medical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Blueberries Medical's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 0.00%.

Blueberries Medical's EBITDA per Share for the three months ended in Dec. 2024 was €-0.00.


Blueberries Medical YoY EBITDA Growth Historical Data

The historical data trend for Blueberries Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueberries Medical YoY EBITDA Growth Chart

Blueberries Medical Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.18 9.52 84.21 -33.33 50.00

Blueberries Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 100.00 - 100.00 -

Blueberries Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Blueberries Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.002--0.004)/ | -0.004 |
=50.00 %

Blueberries Medical's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.001--0.001)/ | -0.001 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blueberries Medical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Blueberries Medical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueberries Medical Business Description

Traded in Other Exchanges
Address
8500 West Georgia Street, Suite 2200, Vancouve, BC, CAN, V6C 3E8
Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.

Blueberries Medical Headlines

No Headlines